Biocartis Group NV: Biocartis and Bristol-Myers Squibb sign collaboration agreement for MSI testing with immuno-oncology therapies
Biocartis Group NV (the ‘Company‘ or ‘Biocartis‘), an innovative molecular diagnostics company, announced the signing of a…
